drugset / Trial / NCT01634568

A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men

NCT01634568

Phase 1 Completed 49 enrolled Vernalis (R&D) Ltd
RandomizedParallel-groupDouble-blindBasic science

Summary

A double-blind, randomised, placebo-controlled study of the safety, tolerability and pharmacokinetics of single and multiple ascending oral doses of V81444 in healthy male volunteers

Timeline

Start
2011-08
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciforadenant Small molecule Oral

Indications